17.5 days), this difference did not reach statistical significance (P = 0.147) ( Table 4 ). 3.5 Safety assessment: nephrotoxicity and other adverse events In the matched cohort, overall AKI incidence was high but showed no significant difference between groups ( Table 4 ).
← all excerpts
Impact of multisite colonization and comparative microbiological outcomes of colistin-sulbactam vs. colistin-tigecycline in CRAB hospital-acquired pneumonia: a propensity score-matched analysis.
1
0.1470
0.1470